New bioanalytical services available:

CYP probe and bile acid cocktail analysis Pharmacelsus has developed new bioanalytical solutions to study drug-related effects on liver functions:

Our bioanalytical lab now offers a rapid, highly-sensitive and cost-efficient method to analyse fourteen major bile acids in a single sample, allowing the generation of a comprehensive bile acid profile in plasma or in vitro samples. In addition we have developed a reliable and swift protocol for the multi-probe analysis of CYP activities, including eight major FDA- and EMA-recommended probes. Both methods support analysis of liver functions in particular in systems with low production rates, such as in vitro microtissues.


Nach oben     zurück


NEBUMA ist „Innovator des Jahres“

Klassensieg bei TOP 100 / Innovationsmanagement und Innovati-onserfolge überzeugen / Ehrung durch Ranga Yogeshwar.


SWG beteiligt sich an der Pxio GmbH, Saarbrücken


Neue Schadstoffsoftware DataCross gestartet

Umweltminister Reinhold Jost hat am 9. Januar 2018 die Neuentwicklung der tec4U-Solutions GmbH o....